Apr 16, 2026 11:53AM White House Prepares Order On Ibogaine Psychedelic - CBS

Mar 27, 2026 03:25AM Deutsche Bank Starts AtaiBeckley Inc (ATAI) at Buy

Mar 18, 2026 07:58AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Mar 10, 2026 07:23AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Mar 9, 2026 06:04AM AtaiBeckley (ATAI) files mixed shelf

Mar 6, 2026 03:37PM Jefferies Reiterates Buy Rating on atai Life Sciences N.V (ATAI): "keen on ATAI's robust BPL-003 Phase IIb TRD results"

Jan 13, 2026 07:02AM atai Life Sciences (ATAI) Reiterated at Overweight by Cantor Fitzgerald

Jan 8, 2026 07:06AM AtaiBeckley outlines 2026 clinical trial timeline ahead of JP Morgan conference

Dec 23, 2025 07:18AM Jones Trading Starts atai Life Sciences N.V (ATAI) at Buy

Dec 11, 2025 07:00AM AtaiBeckley receives US patent for EMP-01 mental health drug

Nov 14, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Nov 12, 2025 07:59AM atai Life Sciences (ATAI) Misses Q3 EPS by 17c

Nov 10, 2025 07:00AM AtaiBeckley reports positive data on second dose of depression drug

Oct 22, 2025 06:23AM atai Life Sciences N.V (ATAI) PT Raised to $14 at Canaccord Genuity, 'significantly undervalued'

Oct 13, 2025 05:51AM Needham Starts atai Life Sciences N.V (ATAI) at Buy

Sep 24, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Sep 24, 2025 06:29AM Canaccord Genuity Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Sep 15, 2025 07:34AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Aug 14, 2025 07:41AM atai Life Sciences (ATAI) Misses Q2 EPS by 2c

Jul 31, 2025 06:43AM atai Life Sciences N.V (ATAI) PT Raised to $15 at H.C. Wainwright

Jul 29, 2025 06:03AM Oppenheimer Starts atai Life Sciences N.V (ATAI) at Outperform

Jul 2, 2025 11:59AM Aegis Capital Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Jul 2, 2025 06:42AM atai Life Sciences N.V (ATAI) PT Raised to $12 at Canaccord Genuity

Jul 2, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Jul 2, 2025 05:38AM Increasing unusual option volume: ATAI BUR INMB FRSH JKS HUYA

Jul 1, 2025 06:05AM atai Life Sciences (ATAI) Announces $50M Private Placement

Jul 1, 2025 06:01AM atai Life Sciences (ATAI) and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003

Jun 6, 2025 06:10AM Lucid Capital Markets Starts atai Life Sciences N.V (ATAI) at Buy

Jun 3, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

May 20, 2025 07:03AM atai Life Sciences (ATAI) Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

May 14, 2025 04:19PM atai Life Sciences (ATAI) Tops Q1 EPS by 1c

May 13, 2025 07:04AM atai Life Sciences (ATAI) Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

Apr 4, 2025 04:55AM Berenberg Starts atai Life Sciences N.V (ATAI) at Positive

Mar 17, 2025 04:44PM atai Life Sciences (ATAI) Misses Q4 EPS by 9c

Mar 5, 2025 07:08AM atai Life Sciences (ATAI) Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression

Feb 12, 2025 04:02PM atai Life Sciences (ATAI) to offer $55 million in stock

Jan 28, 2025 07:00AM atai Life Sciences (ATAI) Announces Positive Topline Results from Beckley Psytech’s BPL-003

Jan 10, 2025 07:04AM atai Life Sciences (ATAI) Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health

Nov 19, 2024 06:43AM atai Life Sciences N.V (ATAI) PT Lowered to $10 at H.C. Wainwright

Nov 13, 2024 04:32PM atai Life Sciences (ATAI) Reports In-Line Q3 EPS

Nov 11, 2024 07:30AM Altimmune (ALT) Appoints Greg Weaver as CFO

Sep 3, 2024 06:47AM H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Aug 15, 2024 10:40AM TD Cowen Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Aug 13, 2024 04:04PM atai Life Sciences N.V (ATAI) PT Lowered to $5 at Jefferies

Aug 13, 2024 08:00AM atai Life Sciences (ATAI) Misses Q2 EPS by 20c

Aug 13, 2024 07:01AM atai Life Sciences (ATAI) Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)

Jul 3, 2024 08:57AM TD Cowen Reiterates Buy Rating on atai Life Sciences N.V (ATAI)

Jun 20, 2024 07:01AM atai Life Sciences (ATAI) Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101